Kannan N - Search Results

1

Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells.

Amiry N, Kong X, Muniraj N, Kannan N, Grandison PM, Lin J, Yang Y, Vouyovitch CM, Borges S, Perry JK, Mertani HC, Zhu T, Liu D, Lobie PE. Amiry N, et al. Among authors: kannan n. Endocrinology. 2009 Oct;150(10):4473-83. doi: 10.1210/en.2009-0066. Epub 2009 Jul 9. Endocrinology. 2009. PMID: 19589871

2

Are trefoil factors oncogenic?

Perry JK, Kannan N, Grandison PM, Mitchell MD, Lobie PE. Perry JK, et al. Among authors: kannan n. Trends Endocrinol Metab. 2008 Mar;19(2):74-81. doi: 10.1016/j.tem.2007.10.003. Epub 2007 Dec 3. Trends Endocrinol Metab. 2008. PMID: 18054496 Review.

3

Transcriptional activation of signal transducer and activator of transcription (STAT) 3 and STAT5B partially mediate homeobox A1-stimulated oncogenic transformation of the immortalized human mammary epithelial cell.

Mohankumar KM, Perry JK, Kannan N, Kohno K, Gluckman PD, Emerald BS, Lobie PE. Mohankumar KM, et al. Among authors: kannan n. Endocrinology. 2008 May;149(5):2219-29. doi: 10.1210/en.2007-1320. Epub 2008 Feb 14. Endocrinology. 2008. PMID: 18276758

4

Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.

Kannan N, Kang J, Kong X, Tang J, Perry JK, Mohankumar KM, Miller LD, Liu ET, Mertani HC, Zhu T, Grandison PM, Liu DX, Lobie PE. Kannan N, et al. Neoplasia. 2010 Dec;12(12):1041-53. doi: 10.1593/neo.10916. Neoplasia. 2010. PMID: 21170268 Free PMC article.

5

HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells.

Mohankumar KM, Xu XQ, Zhu T, Kannan N, Miller LD, Liu ET, Gluckman PD, Sukumar S, Emerald BS, Lobie PE. Mohankumar KM, et al. Among authors: kannan n. Oncogene. 2007 Jun 7;26(27):3998-4008. doi: 10.1038/sj.onc.1210180. Epub 2007 Jan 8. Oncogene. 2007. PMID: 17213808

6

Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma.

Xu XQ, Emerald BS, Goh EL, Kannan N, Miller LD, Gluckman PD, Liu ET, Lobie PE. Xu XQ, et al. Among authors: kannan n. J Biol Chem. 2005 Jun 24;280(25):23987-4003. doi: 10.1074/jbc.M503869200. Epub 2005 Apr 20. J Biol Chem. 2005. PMID: 15845533 Free article.

7

MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity.

Leung E, Kannan N, Krissansen GW, Findlay MP, Baguley BC. Leung E, et al. Among authors: kannan n. Cancer Biol Ther. 2010 May 1;9(9):717-24. doi: 10.4161/cbt.9.9.11432. Cancer Biol Ther. 2010. PMID: 20234184

8

PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.

Thirusangu P, Ray U, Sarkar Bhattacharya S, Oien DB, Jin L, Staub J, Kannan N, Molina JR, Shridhar V. Thirusangu P, et al. Among authors: kannan n. Oncogene. 2022 Aug;41(33):4003-4017. doi: 10.1038/s41388-022-02391-x. Epub 2022 Jul 8. Oncogene. 2022. PMID: 35804016 Free PMC article.

9

DNA barcoding reveals diverse growth kinetics of human breast tumour subclones in serially passaged xenografts.

Nguyen LV, Cox CL, Eirew P, Knapp DJ, Pellacani D, Kannan N, Carles A, Moksa M, Balani S, Shah S, Hirst M, Aparicio S, Eaves CJ. Nguyen LV, et al. Among authors: kannan n. Nat Commun. 2014 Dec 23;5:5871. doi: 10.1038/ncomms6871. Nat Commun. 2014. PMID: 25532760 Free PMC article.

10

Progesterone and Breast Cancer.

Trabert B, Sherman ME, Kannan N, Stanczyk FZ. Trabert B, et al. Among authors: kannan n. Endocr Rev. 2020 Apr 1;41(2):320-44. doi: 10.1210/endrev/bnz001. Endocr Rev. 2020. PMID: 31512725 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

452 results

Search Page